Whittier College

Poet Commons
Biology

Faculty Publications & Research

2016

Osteopontin ablation ameliorates muscular dystrophy by shifting
macrophages to a proregenerative phenotype
Sylvia Vetrone
Joana Capote
Irina Kramerova
Leonel Martinez
Elisabeth R. Barton

See next page for additional authors

Follow this and additional works at: https://poetcommons.whittier.edu/bio
Part of the Biology Commons

Authors
Sylvia Vetrone, Joana Capote, Irina Kramerova, Leonel Martinez, Elisabeth R. Barton, H. Lee Sweeney, M.
Carrie Miceli, and Melissa J. Spencer

JCB: Article

Osteopontin ablation ameliorates muscular
dystrophy by shifting macrophages to a proregenerative phenotype
Joana Capote,1,3 Irina Kramerova,1 Leonel Martinez,1 Sylvia Vetrone,1 Elisabeth R. Barton,6,7
H. Lee Sweeney,5,7 M. Carrie Miceli,2,4,7 and Melissa J. Spencer1,4,7

Downloaded from http://rupress.org/jcb/article-pdf/213/2/275/1372070/jcb_201510086.pdf by guest on 29 October 2020

of Neurology and 2Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los
Angeles, Los Angeles, CA 90095
3Molecular, Cellular, and Integrative Physiology Interdepartmental PhD Program, University of California, Los Angeles, Los Angeles, CA 90095
4Center for Duchenne Muscular Dystrophy at UCLA, Los Angeles, CA 90095
5Department of Pharmacology and Therapeutics, University of Florida, Gainesville, FL 32610
6Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL 32611
7Wellstone Muscular Dystrophy Center, University of Florida, Gainesville, FL 32610

THE JOURNAL OF CELL BIOLOGY

1Department

In the degenerative disease Duchenne muscular dystrophy, inflammatory cells enter muscles in response to repetitive
muscle damage. Immune factors are required for muscle regeneration, but chronic inflammation creates a profibrotic
milieu that exacerbates disease progression. Osteopontin (OPN) is an immunomodulator highly expressed in dystrophic
muscles. Ablation of OPN correlates with reduced fibrosis and improved muscle strength as well as reduced natural killer
T (NKT) cell counts. Here, we demonstrate that the improved dystrophic phenotype observed with OPN ablation does
not result from reductions in NKT cells. OPN ablation skews macrophage polarization toward a pro-regenerative phenotype by reducing M1 and M2a and increasing M2c subsets. These changes are associated with increased expression
of pro-regenerative factors insulin-like growth factor 1, leukemia inhibitory factor, and urokinase-type plasminogen
activator. Furthermore, altered macrophage polarization correlated with increases in muscle weight and muscle fiber
diameter, resulting in long-term improvements in muscle strength and function in mdx mice. These findings suggest that
OPN ablation promotes muscle repair via macrophage secretion of pro-myogenic growth factors.

Introduction
Patients with mutations in the DMD gene have Duchenne
muscular dystrophy (DMD), which is a progressive muscle
degenerative disease that leads to loss of skeletal muscle cardiomyopathy and eventual death (Bushby et al., 2010). In DMD,
defective dystrophin protein causes muscle membrane fragility,
leading to contraction-induced injury caused by high forces on
the cell membrane and leading to cycles of muscle fiber degeneration and regeneration (Vetrone et al., 2009; Heydemann et
al., 2009). Inflammatory cells invade in response to the repeated
waves of damage and repair and release cytokines, which promote pathological fibrosis (Borthwick et al., 2013). Fibrosis
leads to loss of mobility and function and has the potential to
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interfere with gene and stem cell therapies. Inflammatory cells
also secrete promyogenic factors that enable proper myogenic
differentiation and are absolutely necessary for successful muscle repair (Cantini et al., 2002; Dumont and Frenette, 2010;
Saclier et al., 2013). Thus, modulating the inflammatory cell
infiltrate in dystrophic muscle has the potential to target both
fibrosis and regeneration and represents a therapeutic target for
DMD. Such treatment may attenuate disease and improve the
efficacy of other therapies if used in combination.
Macrophages are the predominant immune cell type found
in the inflammatory infiltrate of human DMD and mdx muscles
(McDouall et al., 1990; Wehling et al., 2001). Macrophages that
infiltrate dystrophic muscles are a heterogeneous mix of classically (M1) and alternatively (M2) activated types (Villalta et
al., 2009; Mann et al., 2011). M1 macrophages are classified as
proinflammatory because they express known proinflammatory
mediators (tumor necrosis factor, interleukin [IL]-1β, and IL-6)
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and reactive nitrogen and oxygen intermediates (Mantovani et
al., 2007; Novak and Koh, 2013; Liu et al., 2014; Rigamonti et
al., 2014). M1 macrophages have also been shown to promote
myoblast proliferation and collagen production in fibroblasts
in vitro (Song et al., 2000; Cantini et al., 2002). The alternatively activated M2 macrophages, on the other hand, are a more
heterogeneous group: M2 macrophages can be subdivided into
M2a, M2b, and M2c macrophages (Liu et al., 2014; Rigamonti
et al., 2014; Wermuth and Jimenez, 2015). M2a macrophages
are believed to be fibrosis promoting (Song et al., 2000; Cantini
et al., 2002), whereas M2c macrophages are thought to be deactivating for M1 macrophages and pro-regenerative. Although
the markers for M1 macrophages are fairly well defined, the
markers to distinguish different subpopulations of M2 macrophages are less so, particularly M2c.
Osteopontin (OPN), encoded by the SPP1 gene, is the
most highly up-regulated transcript in dystrophic muscles
(Haslett et al., 2002; Porter et al., 2002). OPN is a multifunctional protein that binds to a vast array of cell surface receptors, (primarily integrins; Bayless et al., 1998; Casals et al.,
2008) to activate diverse signaling pathways including nuclear
factor-κB and protein kinase B. Osteopontin activity has been
shown to affect diverse cellular processes such as bone remodeling, cell motility, cell adhesion, and cell survival (Das et al.,
2005; Nyström et al., 2007; Kahles et al., 2014). Our prior work
identified OPN as a potential immunomodulator that regulates
fibrosis in the mouse model of DMD (Vetrone et al., 2009). In
those studies, OPN ablation correlated with reduced muscle fibrosis, reduced TGF-β, and increased regeneration. Moreover,
we found that OPN ablation altered the inflammatory milieu,
leading to reductions in several immune cell populations such
as natural killer T (NKT) cells and Gr-1+ cells, as well as an increase in FoxP3 mRNA levels (a marker of regulatory T cells).
However, the net effect of these changes in immune cell populations and the specific manner in which OPN ablation alters
dystrophic disease is not completely understood.
Here we elucidate how changes induced by OPN ablation affect the pathogenesis of dystrophinopathies. The data show that OPN
ablation skews dystrophic macrophages toward a pro-regenerative
phenotype, leading to improved and sustained muscle mass and
strength on long-term functional testing. This investigation provides insight into the role of OPN in dystrophic muscle and further
substantiates its value as a therapeutic target for DMD.
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Results
Role of NKT cells in the mdx phenotype

Our previous investigations demonstrated modulation of the
mdx immune infiltrate after OPN ablation (Vetrone et al., 2009).
In those studies, OPN ablation led to a significant decrease in
the frequencies of intramuscular NKT and Gr-1+ cells invading
mdx muscles (Vetrone et al., 2009). NKT cells are T cells that
also express NK cell markers (e.g., NK1.1 or DX5; Godfrey
and Kronenberg, 2004). These cells are activated by glycolipids, which are presented in the context of membrane-bound
CD1d molecules, akin to the manner in which T cells recognize
peptides in the context of major histocompatibility complex
(MHC) class I and II. To determine whether these cells are relevant to the human disease, 10 biopsies from DMD boys ranging from 3 to 9 yr of age were examined for evidence of NKT
cells within the muscle tissue, by using an antibody against the
invariant α chain (Vα24) expressed by human NKT cells. This
analysis confirmed that scattered Vα24+ cells were present in
the biopsies (Fig. 1 A).
To understand whether changes in NKT populations (such
as those observed with OPN ablation) might underlie amelioration of the dystrophic phenotype, we conducted in vivo depletion of NKT cells using an antibody against asialo-GM1, which
was injected into mdx mice. Asialo-GM1 is a well-established
cell surface ganglioside of NK and NKT cells that is necessary
for their complete activation. Treatment with anti–asialo-GM1
has been previously shown to result in a reduction of both cell
types (Slifka et al., 2000; Nakagawa et al., 2001; Nakano et al.,
2002; Byrne et al., 2004). mdx mice were treated from 1 wk
of age until they were assessed for functional and phenotypic
features of muscular dystrophy at 4 and 24 wk of age. To verify
that treatments were effective in depleting NKT cells, we evaluated intramuscular NKT cells in treated mice, using tetramers of
CD1d in conjunction with markers of NK and T cells (Fig. 1 B).
Liver NKT cells were examined in parallel as a positive control.
The analysis showed that GM1 treatment reduced intramuscular
NKT cells (i.e., cells coexpressing CD3+, NK1.1+, and CD1d+
tetramer) by 85% (Fig. 1 B). Tetramer-negative NKT cells (i.e.,
cells expressing CD3+, NK1.1+, and CD1d−) were also depleted
by GM1 treatment, by 83% (Fig. 1 B). In spite of reductions
in NK and NKT cells, attenuation of intramuscular fibrosis or
other features of the mdx phenotype was not observed at either
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Figure 1. NKT cells are observed in muscles
from patients with Duchenne muscular dystrophy and are depleted from mdx muscle and
liver by GM1 treatment. (A) Cross sections
from DMD biopsies were immunostained with
an antibody against Vα24, the invariant chain
of human NKT cells. Positive staining appears
red, and counterstain with hematoxylin labels
the nuclei dark blue and the muscle tissue
light blue. Bar, 100 µm. (B) Quantification of
liver and muscle NKT cells from GM1- or PBStreated animals. The graph shows a representative experiment in which each bar represents
the values obtained from pooled muscles
isolated from three mice injected with PBS
(blue bars) and three mice injected with GM1
(black bars). The plot illustrates the frequency
of CD3+ cells that coexpress either [NK1.1]
or [NK1.1+ CD1d-tetramer]. Numbers shown
represent the amount of depletion attained by
GM1 treatment compared with PBS controls.

the 4- or 24-wk time points (Table 1). Thus, the studies eliminate NKT cells as effectors of the dystrophic phenotype and
suggest that the previously observed phenotypic improvements
on OPN ablation were not a result of reductions in NKT cells.
Macrophage polarization is altered in the
absence of OPN

Levels of F4/80 and Ly6C correlate with
M1, M2a, and M2c macrophage subtypes

To further characterize the phenotype of the macrophage populations that we observed, we used FACS based on their Ly6C
and F4/80 surface expression. After sorting, leukocytes from
4- and 8-wk-old mdx mice were examined for gene expression profiles commonly associated with macrophage subtypes
(Fig. 5). The F4/80lowLy6Chigh macrophages displayed high levels of iNOS expression, with very little or no Arg-1, CD206,
or CD163 expression, thus resembling M1 macrophages. The
other two groups of macrophages, F4/80mediumLy6Cmedium and
F4/80highLy6Clow, were both Arg-1+, CD206+, and CD163+, with
little to no iNOS expression. However, the F4/80mediumLy6Cmedium
group had the highest Arg-1 expression, suggesting that they
resembled the M2a subtype, whereas F4/80highLy6Clow showed
higher CD206 and CD163 expression and low Arg-1, suggesting that these cells align with the profile of M2c macrophages.
Thus, based on these expression profiles, we have defined
F4/80lowLy6Chigh macrophages as M1, F4/80mediumLy6Cmedium as
M2a, and F4/80highLy6Clow as M2c. These data reveal that OPN
ablation in mdx mice alters macrophage polarization toward
decreased M1 and M2a subtypes and increased M2c type macrophages. Overall, the ratios of M1 to M2 are decreased at both
4 and 8 wk of age (Fig. 5 C and Table S1).
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Our prior studies demonstrated that the frequency of Gr-1+ cells
(previously used as a Ly6G marker) was significantly reduced
in OPN−/−mdx muscles (Vetrone et al., 2009). Because the Gr-1
antibody recognizes both Ly6G (a neutrophil-specific marker)
and Ly6C (a pan-granulocyte and macrophage marker) we
sought to further explore the Gr-1+ cell types affected by OPN
ablation. Double-staining of isolated mdx leukocytes with Gr-1
and F4/80 antibodies revealed that neutrophils make up ∼7% of
the total CD45+ leukocytes at 4 wk and 5 mo of age (Fig. 2 A),
which is a smaller percentage of the leukocyte infiltrate than
we had previously estimated (Vetrone et al., 2009). However,
consistent with our prior results, the frequency of neutrophils
was slightly decreased in OPN−/−mdx muscles (Fig. 2 A).
Also consistent with our prior results, there was no change in
the frequency of F4/80+ cells upon OPN ablation. To determine the frequency of eosinophils versus macrophages in the
F4/80+ population, we stained for Siglec F, which is a marker
of eosinophils. Eosinophils comprised ∼15% of all F4/80+
cells (Fig. 2 B), and their frequency was not altered in the absence of OPN (Fig. 2 B).
Examination of the Ly6C marker on isolated leukocytes
revealed a striking shift in its distribution (between Ly6Clow vs.
Ly6Chigh) in OPN−/−mdx mice (Fig. 3 A). Because Ly6C levels
change from high to low as macrophages undergo polarization
(Arnold et al., 2007; Varga et al., 2013; Crane et al., 2014), we
reasoned that the altered Ly6C levels might reflect changes in
macrophage subtypes. To determine whether the observed shift
in Ly6C was caused by a change in macrophage polarization,
we examined sorted F4/80+ cells from 4- and 8-wk-old mdx
mice for expression of Ly6C. To obtain reproducible data, it was
necessary to sort the F4/80+ cells and then exclude the eosinophils, based on side scatter height (SSC-H) and forward scatter height (FSC-H) gating (Fig. 3 B). The macrophages were
subsequently analyzed for Ly6C expression, which revealed
the presence of three distinct populations: (a) F4/80lowLy6Chigh;
(b) F4/80mediumLy6Cmedium; and (c) F4/80highLy6Clow (Fig. 3 C).
Quantitative evaluation of these macrophage populations
showed that the Ly6Chigh and Ly6Cmedium populations were

significantly decreased in the OPN−/−mdx mice, whereas a significant increase was observed in the Ly6Clow population in both
4- and 8-wk-old OPN−/−mdx mice (Fig. 4). A similar tendency
in skewing of macrophage polarization was also observed in
an acute injury model with OPN ablation (Fig. S1). Thus, a
consistent skewing of Ly6C was observed on isolated macrophages from OPN−/−mdx mice.

OPN is a novel marker of M2c
macrophages

We next examined whether OPN is differentially expressed in
the three macrophage subtypes. Analysis of OPN expression
in the sorted populations demonstrated that M2c macrophages
express the highest levels of OPN compared with M1 and M2a
subtypes, suggesting that OPN may be a novel and suitable
marker for identification of M2c macrophages (Fig. 6). To further characterize the expression of OPN in macrophage populations, we evaluated OPN expression in a macrophage cell
line that was induced to polarize according to defined macrophage phenotypes by exposure to specific cytokines. J774A.1

Table 1. Functional and histological features of dystrophic mice treated with GM1
Characteristic

4 wk
mdx-R.sera

Body weight, g
Wire test, seconds on wire
Creatine kinase, IU/L

6 mo
mdx-GM1

Mean ± SD

n

mdx-R.sera

Mean ± SD

n

mdx-GM1

Mean ± SD

n

Mean ± SD

n

11.08 ± 2.2

30

11.61 ± 1.79

29

28.94 ± 4.46

11

29.93 ± 3.9

11

31.83 ± 10.6

23

33.46 ± 13.27

28

18.93 ± 10.76

11

15.6 ± 11.34

11

25,039 ± 11,620

6

26,851 ± 8,997

6

10,745 ± 4,959

6

11,086 ± 3,789

6
9

Histopathology
Quadriceps, % necrotic area

8.04 ± 4.35

6

11.08 ± 5.39

8

3.71 ± 1.27

9

4.82 ± 2.66

Diaphragm, % necrotic area

NA

NA

NA

NA

6.69 ± 2.05

6

6.15 ± 2.22

6

5.11 ± 2.3

13

5.91 ± 3.03

12

NA

NA

NA

NA

5.06 ± 1.61

9

6.79 ± 2.93

10

NA

NA

NA

NA

NCAM, % positive fibers
devMHC, % positive fibers
NA, not applicable.
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Figure 2. Analysis of Ly6C+ cells in OPN−/−mdx infiltrates. (A) Muscle leukocytes were isolated from OPN−/−mdx and OPN+/+mdx muscles, stained
for Gr1 and F4/80, and assessed by flow cytometry. FACS plots show
F4/80 plotted against Gr1. Cells enclosed by the blue square represent
neutrophils. The frequency of neutrophils is indicated in the top right of
each quadrant. (B) Analysis of eosinophils was performed by Siglec F
staining on sorted F4/80+ cells from OPN+/+mdx and OPN−/−mdx muscles. Circled regions in the FACS plots represent the eosinophil population,
and numbers indicate eosinophil frequencies (top). Bottom graphs show
the quantification of F4/80+ cell frequency in the total intramuscular leukocyte population (bottom left) and eosinophils in the intramuscular F4/80+
cell population (bottom right). Black bars represent OPN+/+mdx, and white
bars represent OPN−/−mdx. Animal numbers are indicated on graphs.
P-values were generated by Student’s t test. Vertical lines represent SEM.

macrophages were exposed to IFNγ, IL-4, or IL-10, and their
expression of traditional macrophage polarization markers was
assessed: inducible nitric oxide synthase (iNOS) for M1, Arg-1
for M2a, and IL-10 for M2c macrophages (Fig. 7 A). We observed that expression of iNOS, Arg-1, and IL-10 was induced
by IFNγ, IL-4, and IL-10 treatment, respectively, suggesting
that the macrophages polarized as expected; however, we observed that IL-10 expression was also induced in cells treated
with IFNγ, suggesting that IL-10 is not a specific M2c marker
(Fig. 7 A). Additionally, we observed that OPN expression was
specifically induced in M2c macrophages treated with IL-10, at
both the RNA (Fig. 7 C) and protein (Fig. 7 D) levels, suggesting
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Figure 3. Evaluation of macrophage polarization by cell sorting and
FACS analysis. (A) Representative FACS plots of muscle-infiltrating leukocytes stained for Ly6C and plotted against SSC for OPN+/+mdx and
OPN−/−mdx. (B) Demonstration of the purity of MACS sorting. The top
left FACS plot shows F4/80 staining of the negatively sorted population,
and the top right FACS plot shows F4/80 staining of the positively sorted
population. Positively sorted cells (arrow) were examined by SSC and FSC
to isolate macrophages (larger population on the right) from eosinophils
(left). The bottom right FACS plot shows Ly6C isotype control staining
on the macrophage population used in these studies. (C) Representative
FACS plots of MACS-sorted F4/80+ macrophages stained for F4/80 and
Ly6C. Circled regions represent distinct macrophage populations. Experiments were done at 4 and 8 wk of age. Quantification of these experiments is shown in Fig. 4.

Figure 4. Macrophage polarization is
skewed in OPN−/−mdx muscles. Quantification of macrophage subpopulations from
MACS-sorted F4/80+ macrophages isolated
from OPN+/+mdx and OPN−/−mdx muscles.
Plots depict mean values of pooled data from
4-wk-old (top) and 8-wk-old (bottom) mice,
assessed as described in Fig. 3. Vertical lines
represent standard errors. Animal numbers are
indicated on each bar of the graph. Statistical significance determined by Student’s t test.
P-values are indicated.

OPN ablation promotes the expression
of pro-regenerative factors from mdx
macrophages

Because the phenotype of tissue macrophages dictates the
manner in which they influence a disease process, we sought to
identify the functional outcome of the observed shift in macrophage polarization in the setting of OPN ablation in mdx
mice. To this end, we assessed the expression of profibrotic
and pro-regenerative factors by RT-PCR on sorted F4/80+ cells
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that OPN is most highly expressed in this subtype of macrophage. The data show that OPN is a marker that distinguishes
M2c macrophages from M1 and M2a types. To our knowledge,
this finding suggests that OPN may represent the first specific
M2c macrophage marker.

isolated from OPN−/−mdx and OPN+/+mdx muscles. Based on
the previous observations of reduced fibrosis in OPN−/−mdx
muscles (Vetrone et al., 2009), we expected to detect a decrease
in profibrotic cytokines such as TGF-β. However, no significant differences were observed in the expression of different
profibrotic factors such as fibronectin (Vidal et al., 2008),
C-C chemokine ligand 17 (Belperio et al., 2004), and TGF-β
(Vidal et al., 2008; Fig. 8 A). On the contrary, OPN−/−mdx
macrophages showed significantly increased expression of
pro-regenerative factors, such as insulin-like growth factor 1
(Barton et al., 2002), leukemia inhibitory factor (Hunt et al.,
2013), and urokinase plasminogen activator (Suelves et al.,
2007; Fig. 8 B). Thus, OPN ablation appears to skew macrophages toward a pro-regenerative macrophage phenotype
in dystrophic muscles.
Figure 5. Levels of F4/80 and Ly6C correlate
with M1, M2a, and M2c macrophage subtypes. Quantitative RT-PCR was used to evaluate mRNA expression of phenotypic markers
from sorted macrophage populations isolated
from muscles of 4-wk-old (A) or 8-wk-old (B)
mice. Macrophage populations were defined
and sorted (according to F4/80 and Ly6C levels) from a single sample of pooled muscles
collected from six 4-wk-old mice (A) and six
8-wk-old mice (B). Samples were run in triplicate to measure the expression of these genes.
All values are expressed relative to GAPDH.
(C) Graph of M1 vs M2 ratios at 4 and 8 wk
of age. Vertical lines represent SEM.
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OPN ablation induces long-term amelioration
of the dystrophic phenotype in mdx mice

OPN ablation correlates with increased
muscle mass and fiber diameter

The observed increase in pro-regenerative growth factors is consistent
with our prior study of increased regenerating fibers in OPN−/−mdx
muscles (Vetrone et al., 2009). To determine whether the observed
shift toward a pro-regenerative macrophage phenotype on OPN ablation leads to overall increases in muscle mass, we examined muscle
weight and fiber diameter in the two genotypes of mice. Quadriceps
muscles were carefully dissected and weighed, and the muscle weight
was normalized to tibia length. This analysis showed a significant
increase in quadriceps muscle mass at 3 mo, 6 mo, and 1 yr of age
(Fig. 9). Extensor digitorum longus (EDL) muscle mass was also
significantly increased at 6 mo of age (Fig. 9). Because the EDL
is a small muscle with parallel fiber architecture, we also assessed
the number of fibers and fiber diameter in this muscle. Although the
number of fibers per cross-sectional area did not differ between genotypes, we observed an overall increase in the fiber cross-sectional
area in OPN−/−mdx EDL. Examination of the distribution of the fiber
diameters revealed that the differences were in the smallest and largest fibers, suggesting that two processes were being affected in the
OPN−/−mdx: muscle regeneration and muscle growth.

Discussion
In this investigation, we sought to understand the manner in
which OPN ablation attenuates the severity of muscular dystrophy using the mdx mouse model. Several leukocyte populations were evaluated as a follow-up to our prior investigation
in which we observed changes in NKT and Gr-1+ cells in
OPN−/−mdx mice (Vetrone et al., 2009). Here we demonstrate
that the reduced frequency of NKT cells on OPN ablation
(Vetrone et al., 2009) does not contribute to the amelioration of
dystrophic pathology: depletion of greater than 80% of NKT
cells in mdx muscles did not improve phenotypic features of the
disease (Table 1). Thus, our results confirm that these cells are
not disease promoting in dystrophinopathies and that reductions
in NKT cells do not play a causal role in the improvements that
occur in OPN−/−mdx mice.

Figure 7. In vitro polarization of macrophages reveals high expression of OPN in
M2c macrophages. The J774A macrophage
cell line was induced to different macrophage
subtypes by exposure to polarizing cytokines
in vitro to model macrophage polarization.
Exposure to IFNγ polarizes to M1, exposure
to IL4 polarizes to M2a, and exposure to IL10
polarizes to M2c. NT, not treated. Polarizing treatments are indicated under each bar
of the graph. (A) Expression of iNOS (M1),
Arg-1 (M2a), and IL-10 (M2c) was assessed
by quantitative RT-PCR to confirm macrophage
phenotype (top). (B) Quantitative RT-PCR assessment of OPN mRNA expression in polarized macrophages. Each bar in the plots from
A and B represents the mean value calculated
from six samples collected in three different experiments. (C) Western blot of polarized macrophage extracts reveals high OPN in M2c
macrophages. Polarizing cytokines are indicated above the lanes. Vertical bars represent
standard error. P-values relative to nontreated
cells are indicated based on Student’s t test.
280
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Figure 6. Assessment of OPN mRNA levels in FACS-sorted macrophage
populations. Graph demonstrates data derived from quantitative RT-PCR of
OPN mRNA from sorted macrophage subtypes. Macrophage populations
were defined and sorted (according to F4/80 and Ly6C levels) from a single sample of pooled muscles collected from six 8-wk-old mice and characterized as shown in Fig. 5. Expression of OPN was normalized to GAPDH.
Samples were run in triplicate to measure the expression of both genes.

To determine whether the improvements in muscle mass that
we observed led to long-term consequences for the health
and function of dystrophic muscles, we performed noninvasive functional muscle testing and physiological muscle
strength tests on OPN−/−mdx and OPN+/+mdx mice over a
long time course. These studies revealed that OPN ablation
led to a sustained improvement in muscle strength in dystrophic mice (Fig. 10). OPN−/−mdx mice performed better
on wire hanging (Fig. 10 A), grip strength (Fig. 10 B), and
wire mesh (Fig. 10 C) tests, without large changes in body
weight (Fig. 10 D). Physiological testing of single isolated
EDL, soleus, and diaphragm muscles from OPN−/−mdx mice
showed a significant increase in specific force (Fig. 10 E).
Moreover, we observed significantly reduced serum creatine
kinase (Fig. 10 F) and improved pulmonary function (based
on improved minute ventilation and peak expiratory flow as
shown in Fig. 10, G–I). Thus, these studies reveal that the
pro-regenerative phenotype observed in OPN−/−mdx macrophages correlates with long-term improvements in muscle
strength and function.

Figure 8. OPN ablation promotes a pro-regenerative macrophage phenotype. F4/80+
sorted macrophages were collected from
8-wk-old mice and assessed by quantitative
RT-PCR for profibrotic factors fibronectin, C-C
chemokine ligand 17 (CCL17), and TGF-β
(A) and pro-regenerative factors insulin-like
growth factor 1 (IGF), leukemia inhibitory factor (LIF), and urokinase plasminogen activator
(uPA). (B) Each sample was collected from a
single mouse. The number of samples per experiment is indicated on the bars. Vertical lines
indicate SEM. P-values are shown based on
Student’s t test comparison.
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An important finding of this investigation is the role that
we revealed for OPN in macrophage polarization in the setting
of dystrophinopathy. Shifts in macrophage phenotypes have
been previously proposed to influence the course of mdx dystrophy (Villalta et al., 2009, 2011a,b), whereby reductions in
IFNγ, iNOS, or C-C chemokine receptor 2 reduce the M1/M2
ratio and attenuate disease (Villalta et al., 2011a; Mojumdar et
al., 2014), whereas IL-10 ablation increases the M1/M2 ratio
and exacerbates disease (Villalta et al., 2011b). In agreement
with the previous findings, we show here that the OPN ablation-induced decrease in the M1/M2 ratio of mdx macrophages
improves the dystrophic phenotype and increases muscle mass
and strength. In addition, we identify OPN as a potential new
marker of M2c macrophages. Our studies show that OPN is
more specific than CD163 and IL-10 in identifying the M2c
macrophage subtype, both in vivo and in vitro.
The increased muscle strength observed in this investigation is highly likely to be related to the significant increase in
macrophage expression of pro-regenerative factors insulin-like
growth factor 1 (Barton et al., 2002), leukemia inhibitory factor
(Barton et al., 2002; Hunt et al., 2013), and urokinase plasminogen activator (Suelves et al., 2007; Bryer et al., 2008). At the
same time, no significant difference was observed in the expression of profibrotic factors such as fibronectin (Vidal et al., 2008;
To and Midwood, 2011), C-C chemokine ligand 17 (Belperio
et al., 2004; Yogo et al., 2009), and TGF-β (Fig. 8). The increase in pro-regenerative factors agrees with the relative shift
toward M2c macrophages that we observed with OPN ablation,
because M2c macrophages have been traditionally classified as
the pro-regenerative macrophage subtype.
The effect of OPN ablation on macrophage polarization
may be direct or indirect. OPN has been previously shown to
suppress iNOS and IL-10 expression and induce IL-12, IL-6,
tumor necrosis factor, and IL-1β expression in a variety of in
vitro macrophage models (Rollo et al., 1996; Rollo and Denhardt, 1996; Ashkar et al., 2000; Koguchi et al., 2002; Weber
et al., 2002; Naldini et al., 2006; Gao et al., 2007). Future
studies are needed to gain insight into the specific relationship between OPN and macrophage polarization in the context of dystrophic muscles.
We previously observed reductions in TGF-β in muscles
of OPN−/−mdx mice, but the results here reveal that alterations
in TGF-β levels are not caused by the observed shift in macrophage polarization. Magnetic-activated cell sorting (MACS)

allowed us to more specifically evaluate the cytokine contribution of macrophages to the dystrophic milieu and eliminate
macrophages as the source of reduced TGF-β on OPN ablation.
This result leaves us without an explanation for why OPN ablation reduces TGF-β levels in dystrophic muscles. OPN biology
is complex, and thus intensive studies on isolated cell types will
be required to fully elucidate all of the pathways it regulates in
dystrophic muscle. OPN binds to a large number of different integrins, as well as to the glycoprotein CD44, and may affect different cell types including fibroblasts (Goodison et al., 1999).
OPN can also be retained intracellularly or posttranslationally
modified by cleavage, phosphorylation, and glycosylation, thus
adding complexity to understanding its role in dystrophy. More
studies are necessary to fully understand which of its targets and
signaling pathways are involved in DMD.
The changes induced in the macrophage population by
OPN ablation correlated with improved muscle strength and
function: OPN−/−mdx mice were stronger than OPN+/+mdx
mice. mdx mice lacking OPN were able to hang 1.2–8 times
longer than mdx mice when tested in the wire and mesh tests, at
most ages tested. They also had less muscle damage, as shown
by a significant decrease in serum creatine kinase levels. Additionally, we showed that OPN ablation in mdx mice improved
respiratory function, suggesting that diaphragm muscle pathology is reduced. Although there was a significant improvement
in the dystrophic phenotype, OPN ablation does not restore
mdx mice muscle strength back to normal (Fig. S2). We anticipate that OPN inhibitors would be beneficial and could be
used in combination therapy with other agents to slow disease
progression and improve muscle function.
The complex biology of OPN and its multifaceted impact on signaling pathways in different cells types may provide
an explanation for conflicting studies about OPN as a disease
modifier of DMD. Kyriakides et al. (2011) identified a single
nucleotide polymorphism (SNP) in the promoter of the OPN
gene (SPP1) that correlated with a more severe disease course,
compared with the more common haplotype. The SNP is found
in the AP1 binding site, very close to the translational start site
of the protein. In that initial study, patients with the GG/TG
SNP lost ambulation sooner than patients with the TT SNPs
and expressed 2.7-fold higher levels of OPN. Although a few
subsequent studies on this modifier were inconclusive, follow-up study confirmed the modifier effect, but interestingly,
the effect was observed only in steroid-treated patients (Bello
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Figure 9. OPN ablation leads to increased
muscle mass and size. The quadriceps and EDL
muscles were evaluated for muscle mass at the
ages indicated and data were normalized per
tibial length. All cross sectional area and fiber
analyses were conducted on the EDL. Vertical
lines represent standard error. *, P < 0.05;
#, P ≤ 0.02, determined by Student’s t test.
Bars, 500 µm. CSA, cross-sectional area. Average fiber cross-sectional area was calculated
from n = >9,000 fibers per genotype per age.

Materials and methods
Animals

C57BL/6J, mdx (C57BL/10ScSn-Dmdmdx/J), and OPN-knockout mice
(OPN-KO, B6.Cg-Spp1tm1Blh/J) were obtained from the Jackson Laboratory. The mdx mice have a point mutation on exon 23 that generates
a premature stop codon, leading to loss of expression of the full-length
282
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form of the dystrophin protein (Sicinski et al., 1989). On the other hand,
OPN ablation in the OPN-KO mice was attained by replacing exons 4–7 of
the SPP1 gene with the phosphoglycerokinase neomycin resistance gene
(Liaw et al., 1998). OPN−/−mdx and OPN+/+mdx mice came from colonies
previously established in the laboratory (Vetrone et al., 2009) by breeding
male OPN-KO mice with homozygous mdx females, which later resulted
in OPN+/−mdx mice that were crossed between them to obtain OPN−/−mdx
and OPN+/+mdx mice. These colonies have been maintained in the University of California, Los Angeles (UCLA), vivarium by homozygous crosses.
OPN−/−mdx and OPN+/+mdx colonies are in a mixed C57BL10/C57BL6
background with a predominance of the C57BL10 background (∼60% as
determined by congenic analysis). All mice used in these experiments were
genotyped using previously published protocols (Amalfitano and Chamberlain, 1996; Liaw et al., 1998) for the OPN and dystrophin mutations,
respectively. All animals were handled and bred according to guidelines
stipulated by the Animal Research Committee at UCLA.
Intramuscular cardiotoxin injection

Quadriceps muscles from 3-mo-old C57BL/6J and OPN-KO mice
were injected once with 100 µl of a 10-µM cardiotoxin solution (CTX;
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et al., 2015). Studies in the dog model of DMD have demonstrated that levels of OPN correlate with degree of disability in
different muscles (Galindo et al., 2015). Therefore, modulation
of OPN has been demonstrated in mice, dogs, and humans to
affect disease progression.
This study suggests that modulating immune cell infiltrates toward a more pro-regenerative phenotype may slow
down disease progression and improve muscle function in
the dystrophinopathies. Furthermore, it provides insight into
OPN-mediated mechanisms of mdx dystrophy and supports the
development of OPN inhibitors to treat DMD.
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Figure 10. Long-term improvements in muscle strength observed by functional and physiological testing of OPN−/−mdx mice. (A) Hanging wire test (n =
≥9 per genotype and age). (B) Grip strength test (n = ≥9 per genotype and age). (C) Wire mesh test (n = ≥10 per genotype and age). (D) Body weight (n
= ≥9 per genotype and age). (E) Specific force (n indicated on bars of the graph). (F) Serum creatine kinase (n = ≥6 per genotype and age). (G) Minute
ventilation (n = ≥10 per genotype and age). (H) Peak inspiratory flow (n = ≥10 per genotype and age). (I) Peak expiratory flow (n = ≥10 per genotype
and age). Vertical lines represent standard error. *, P < 0.05; #, P ≤ 0.02, determined by analysis of variance model.

cardiotoxin from Naja mossambica mossambica; Sigma-Aldrich)
using a glass syringe (Hamilton Co.) with a 32-gauge needle (Hamilton
Co.). CTX-injected muscles were dissected at 12, 24, 48, and 72 h after
injection to be used for leukocyte isolation.

the technician slowly pulled the mouse by the tail until the digital gauge
recorded the peak tension produced (in newtons [N]). Data are reported
as a mean of the peak tension recorded in the five trials.
Wire mesh test

GM1 treatment of animals

Mdx mice were treated with an intraperitoneal injection of 30 µl of
1.1-mg polyclonal anti-asialo GM1 (CL8955; Cedarlane Laboratories)
or polyclonal rabbit sera as a control (Invitrogen) twice a week. For all
studies, injections began at 6 d of age and continued until mice reached
4 or 24 wk (6 mo) of age.
Wire test

Mice were tested by wire test as previously described (Vetrone et al.,
2009). In brief, mice were placed on a wire secured 2 feet above a safety
net and allowed to use forelimbs and hindlimbs (but not tails) to hang.
Each mouse was subjected to five trials, with 1 min of rest between trials. Hang time was recorded from the moment the experimenter placed
the mouse onto the wire until the mouse fell onto the safety net. The
five data points were averaged and data expressed in seconds.
Grip strength

Forelimb grip strength was measured using a digital force gauge (DFIS
2; Chatillon CE). Five trials were performed with 30 s of rest in between. In each trial, the mouse was allowed to grasp a metal rod and

To assess overall muscle strength in vivo, mice were tested by wire mesh
(custom built in the laboratory of M.J. Spencer). In brief, mice were
placed in the center of a wire mesh pulled over a square wooden frame on
a swivel. The apparatus was placed ∼1.5 ft over a cushioned floor. Once
the mouse was in position, the wire mesh was rotated 180°, resulting in
the mouse hanging upside down from the mesh. Because of the structure
of the mesh, mice were only able to hang on to the mesh using their hindlimb and forelimb paws. Hang time was recorded from the moment the
experimenter began to rotate the mesh until the mouse fell off the mesh.
Each mouse was subjected to five trials, with 1 min of rest between trials.
The mean hang time across five trials was calculated for each mouse.
Isolated muscle mechanics

Muscle-specific force measurements from isolated EDL, soleus, and
diaphragm muscles of 7-mo-old OPN+/+mdx and OPN−/−mdx mice
were performed as previously described (Barton et al., 2010; Moorwood et al., 2013). In brief, mice were anesthetized with ketamine/
xylazine and executed; muscles were removed and placed in a bath of
Ringer’s solution gas-equilibrated with 95% O2/5% CO2. Sutures were
attached to the distal and proximal tendons of the EDL and soleus
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muscles and to the central tendon and rib of the diaphragm preparations. Muscles were subjected to isolated mechanical measurements
using a previously described device (Aurora Scientific; Barton et
al., 2005) and bathed in Ringer’s solution gas-equilibrated with 95%
O2/5% CO2. After determining optimum length (Lo) by supramaximal
twitch stimulation, maximum isometric tetanus was measured in the
muscles during a 500-ms stimulation. Upon completion of these measurements, samples were rinsed in PBS, blotted, and weighed. Muscle
cross-sectional areas were determined using the following formula:
CSA = m/(Lo × L/Lo × 1.06 g/cm3), where m is muscle mass, Lo is
muscle length, L/Lo is the ratio of fiber length to muscle length, and
1.06 is the density of muscle.
Whole-body plethysmography

Mice were sacrificed, and all muscles (hindlimb, pectoralis, diaphragm,
and abdominal) from each mouse were collected and pooled together
into a Petri dish containing sterile Ca2+,Mg2+-free PBS. Tissues were
washed twice with sterile Ca2+,Mg2+-free PBS and then minced and
digested into collagenase type 2 (Worthington Biochemical Corp.) solution (1,700 U/ml) at 37°C with slow agitation. Once the tissue was
digested, the sample volume was raised with sterile Ca2+,Mg2+-free PBS
to stop the digestion and passed through a 70-µm cell strainer. Cells
were pelleted by centrifugation of the filtered mix at 900 g for 5 min.
Supernatant was discarded, and the pellet was resuspended in ammonium-chloride-potassium lysing buffer for 5 min to lyse the red blood
cells. The lysing process was then stopped by raising the volume of the
sample with sterile Ca2+,Mg2+-free PBS, and the suspension was centrifuged at 900 g for 5 min to collect the cells. The cell pellet was suspended again in sterile Ca2+,Mg2+-free PBS and passed through a 40-µm
cell strainer. The filtered cell suspension was then centrifuged at 900 g
for 5 min, the supernatant was discarded, and the cell pellet was resuspended in a small volume of sterile Ca2+,Mg2+-free PBS. At this point, a
small fraction of the sample was mixed 1:1 with 0.4% Trypan blue solution, and the number of unstained cells in the sample was counted using
a hemocytometer. The concentration of viable cells in the sample and
the total number of viable cells was then assessed using the following
formulas: viable cells/ml = unstained number of cells × dilution factor
× 104; total viable cells = viable cells/ml × final volume of the sample.
MACS of isolated macrophages

Macrophage isolation from the total leukocyte population was performed using Miltenyi Biotec MACS technology. Isolated intramuscular leukocyte samples were first blocked with an antibody against
CD16/CD32 (anti-mouse, clone 93; Biolegend) to decrease nonspecific
labeling and then stained with fluorescently labeled anti-F4/80 (rat
anti-mouse, clone BM8, either PE- or APC-labeled; eBioscience). We
used the company protocol for cell labeling and separation, with magnetic nanoparticles coated with antibodies against the fluorescent label
used for the primary antibody (either anti-PE– or anti-APC–coated microbeads; Miltenyi Biotec).
FACS of isolated macrophages

Serum creatine kinase

Blood samples were collected by retroorbital puncture using heparinized
capillary tubes and transferred to serum-separating tubes. Samples were
kept at RT for 15 min to allow the blood to clot and then centrifuged at
3,400 g for 10 min to separate the serum. Once separated, serum was
collected and stored at −80°C. Creatine kinase activity in blood was
estimated using the Creatine Kinase-SL kit from Sekisui Diagnostics,
according to the manufacturer’s instructions. In brief, serum samples
were diluted 1:50 (vol/vol) with sterile Ca2+,Mg2+-free PBS. Controls
for this test were established using the commercial control serums DCTROL level-1 and level-2 (Sekisui Diagnostics). Samples and controls
were set in triplicate in a 96-well plate and mixed with the reaction
buffers provided in the kit. Absorbance of the samples was measured at
340 nm using a Synergy HT multidetection microplate reader (Biotek
Instruments). Creatine kinase concentration was reported in units per
liter and calculated using the following equation:
ΔAbs × TV × 1, 000

	
CK (U/L) =     _______________
  
d × ε × SV ,
where ΔAbs = mean absorbance change per minute; TV = total reaction
volume (ml); d = light path (cm); ε = millimolar absorptivity of NADH
(6.22); SV = sample volume (ml); and 1,000 = conversion of U/ml to U/l.
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MACS-sorted F4/80+ samples were labeled with fluorescently tagged
antibodies against Ly6C (rat anti-mouse, Clone HK1.4; Biolegend),
Siglec-F (rat anti-mouse, clone E50-2440; BD Biosciences), or their
respective isotype controls (Rat IgG2c,K and Rat IgG2a,k, respectively). Fluorescently labeled samples were sorted using a FACScalibur
(Becton Dickinson) flow cytometer. Acquisition parameters (voltage,
gain, etc.) were adjusted with aliquots of the same samples to obtain
the maximum dynamic range of SSC-H, FSC-H, and fluorescence (at
the different channels). FACS acquisition files were analyzed using
FlowJo analysis software.
Macrophage subtype isolation using FACS

Six 4-wk-old and six 8-wk-old OPN+/+mdx mice were used to isolated
the individual macrophage subtype populations. Muscles (hindlimb,
pectoralis, diaphragm, and abdominal) from all six mice were pooled
together, and intramuscular leukocyte isolation was performed as described earlier. Isolated intramuscular leukocyte samples were first
blocked with an antibody against CD16/CD32 (anti-mouse, clone 93;
Biolegend) to decrease nonspecific labeling and then dually stained with
anti-F4/80-APC (rat anti-mouse, clone BM8; eBioscience) and anti–
Ly6C-FITC (rat anti-mouse, clone HK1.4; Biolegend). Fluorescently
labeled samples were sorted using a FACSARIA III (Becton Dickinson). Unlabeled samples were used as control. Acquisition parameters
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Respiratory function was measured in conscious, unrestrained mice using
a whole-body plethysmograph (Buxco, Data Sciences International). In
this system, mice are placed in a chamber that allows them to breathe naturally, unrestrained and untethered. The system measures the small changes
in the air that is exchanged in and out of the entire chamber because of
the animal’s respiration (box flow). Each chamber was calibrated before
every experiment, selecting the most appropriate response observed in
FinePoint Software (Buxco, Data Sciences International) to the injection
of 1 ml air into the chambers. Once all chambers were calibrated, mice
were placed into chambers and allowed to acclimate for 55 min. A Bias
Flow Regulator (Buxco, Data Sciences International) was used to prevent
a rise in CO2 concentration during the acclimation and room air breathing
periods. After acclimation, baseline respiratory function was measured for
5 min. Subsequently, mice were subjected to two hypercapnic challenges
in which a flow of 1 ml/min of 8% CO2/21% O2/balance N2 (Praxair) was
injected for 5 min into the chamber. Between the two hypercapnic challenges, mice were allowed to return to room air breathing for 10 min to
evaluate their capability to recover. All data were collected and analyzed
using FinePoint Software, which uses complicated algorithms that include
variables affecting respiratory function, such as humidity and temperature,
to calculate from the measured box flow the physiological values of the
respiratory parameters from the animal. Mice were weighed before the
beginning of the experiment. Minute ventilation and peak flow values were
normalized to body weight.

Muscle-infiltrating leukocyte isolation

(voltage, gain, etc.) were adjusted with aliquots of the same samples to
obtain the maximum dynamic range of SSC-H, FSC-H, and fluorescence (at the different channels). Macrophage population limits were
established using gates resembling those of the analytical experiments.
Macrophage culture and polarization treatments

The murine monocyte/macrophage cell line J774A.1 (ATCC) was
used as the in vitro macrophage model. Macrophages were grown and
maintained in macrophage growth medium (DMEM, 1% penicillin/
streptomycin, and 10% FBS), and subculture was prepared by scraping. Macrophage polarization was attained by incubation of the macrophage cultures with growth medium supplemented with 100 ng/ml
murine IFNγ, IL-4, or IL-10 (BD) to polarize the cultures to M1, M2a,
or M2c macrophages, respectively.

Livers were removed and dissociated using the end of a 5-cc syringe
plunger and a 70-µM cell strainer. Cell suspensions were centrifuged at
900 g for 6 min at RT. Cell pellets were resuspended in 0.85% ammonium chloride and incubated at RT for 10 min to lyse red blood cells.
After incubation, suspensions were diluted with Dulbecco’s PBS without Ca+ and Mg+ (Invitrogen) to stop the lysing process and centrifuged
for 6 min at 900 g. Pellets were resuspended in 40% Percoll and loaded
to the top of a Percoll gradient (70% Percoll at bottom and 40% at top).
Tubes were then centrifuged at RT for 20 min at 2,000 rpm. The cells at
the interface were collected and washed, and the resulting pellets were
resuspended in PBS and counted.
Antibody staining for flow cytometry of NKT cells

Muscle leukocyte suspensions were incubated with anti-CD16/CD32
(anti-mouse, clone 2.4G2; BD) to block binding to Fc receptors before staining. The following mouse mAbs used for staining were all
obtained from BD: CD3e (hamster anti-mouse, clone 145-2C11),
Vβ8.1/8.2 (mouse anti-mouse, clone MR5-2), NK1.1 (mouse antimouse, clone PK136), and pan-NK (rat anti-mouse, clone DX5). Antibodies were conjugated to FITC, PE, and/or Cy5. The following
antibodies were biotinylated and revealed with Tricolor-conjugated
streptavidin (Ebioscience): anti–asialo-GM1 (CL8955; Cedarlane Laboratories) or rabbit sera (control; Invitrogen). Optimal working dilutions were determined for each antibody before use. All incubations
were performed in Ca+,Mg+-free Dulbecco’s PBS (Invitrogen) at 4°C
for 30 min. After the last wash, 103 live cells per sample were acquired
on a FACScalibur (Becton Dickinson) and analyzed with CELL Quest
Pro software (Becton Dickinson). CD1d tetramers were obtained from
the National Institutes of Health Tetramer Core Facility.
Immunohistochemistry

Muscles were dissected, placed on balsa wood, coated with Tissue Tek
O.C.T. (optimal cutting temperature; Sakura Finetek) mounting media,
and frozen in isopentane cooled by liquid nitrogen. Diaphragm muscles
were cut in half down the midline and rolled before freezing. Sections
were cut on a Micron HM 505E cryostat (10 µm thick; Micron Instruments) and stored at −20°C until use. Immunohistochemistry was
performed as previously described (Kramerova et al., 2004). In brief,
sections were thawed at RT for 30 min then treated with 0.3% H2O2
for 5 min and blocked in PBS with 0.2% gelatin, 0.5% Tween-20, and
3% BSA for 30 min. When necessary, binding to endogenous mouse
IgG was blocked with a mouse on mouse kit (MOM; Vector Laboratories). Sections were later incubated with antibodies against T cell
receptor Vα24 (eBioscience) to identify NKT cells in human biopsies,
CD11b (clone M1/70; BD Biosciences) to emphasize areas of inflammation, or stained with neural cell adhesion molecule (NCAM; clone
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Isolation of liver NKT cells

H28.123; Chemicon International) or developmental myosin heavy
chain (devMHC, clone RNMy2/9D2; Novacastra) to emphasize regenerating fibers. Biotin-conjugated antibodies (Vector Laboratories) were
used as secondary antibodies, followed by incubation with avidin-conjugated horseradish peroxidase and staining with the AEC substrate kit
(Vector Laboratories). To evaluate the cross-sectional area of muscles
and fibers, muscle sections were immunolabeled with laminin antibodies. Sections were thawed at RT for 30 min, washed in PBS, blocked
in PBS with 0.2% gelatin, 0.5% Tween-20, and 3% BSA for 30 min,
incubated with anti-laminin antibody (L9393; Sigma-Aldrich) for 1 h,
washed in PBS, and incubated with fluorescein anti-rabbit antibody
(Vector Laboratories) for 1 h. Finally, sections were washed in PBS,
fixed with 2% paraformaldehyde solution for 10 min, washed again in
PBS, and mounted with DAPI mounting media (Vector Laboratories).
Muscle sections were imaged using an Axio Imager M1 microscope
(ZEISS) equipped with an AxioCam HRc camera (ZEISS). Mosaic
images of the muscle sections were taken using a 10× EC Plan-NEO
FLUAR objective (NA 0.3; ZEISS) and zoomed images were acquired
using a 20× EC Plan-NEOFLUAR objective (NA 0.5; ZEISS). Images
were acquired, processed, and analyzed using the proprietary software
Axiovision 4.8.1 (ZEISS).
Histopathology index

Muscle necrosis was quantified from the muscle sections labeled with
anti-CD11b antibody as the sum of the labeled (CD11b+) areas in a section, normalized by the total cross-sectional area of the muscle section.
Similarly, muscle regeneration was evaluated from the muscle sections labeled with anti-NCAM or anti-devMHC antibodies by counting the number of both small-diameter myotubes and large-diameter
regenerating myofibers positively labeled with NCAM or devMHC,
and normalizing this by the total cross-sectional area of the muscle.
Cross-sectional areas were measured using Axiovision 4.8.1. All analyses were performed blindly.
Western blot

Cell culture samples were lysed in reducing sample buffer (50 mM
Tris-HCl, pH 6.8, 10% glycerol, 2% SDS, and 100 mM β-mercaptoethanol) supplemented with protease and phosphatase inhibitors. Bromophenol blue (0.1%) was added, and samples were boiled at 100°C
for 5 min for protein denaturation. SDS-PAGE and Western blotting
were performed as previously described (Kramerova et al., 2004).
BenchMark protein ladder was used as a molecular weight marker in
every gel. Proteins were separated by gel electrophoresis and transferred into a nitrocellulose membrane. Membranes were blocked with
5% milk in TBS-T (Tris-buffered saline, 0.1% Tween) and incubated
with 1:500 anti-mouse OPN antibody (AF808; R&D Systems) solution in 5% milk TBS-T overnight at 4°C. Membranes were washed
and incubated with HRP-conjugated secondary antibody in 5% milk
TBS-T. The chemiluminescence substrate kit, ChemiGlow West (Protein Simple), was used to detect the protein bands. Chemiluminescent
signals were detected and densitometry analyzed using the FluorChem
FC2 system (Alpha Innotech).
Quantitative RT-PCR

RNA was isolated and quantitative RT-PCR performed as previously
described (Ermolova et al., 2014). In brief, total RNA was isolated from
cell cultures and isolated cells using Trizol reagent (Invitrogen) according to the manufacturer’s protocol. Genomic DNA contamination
was removed by DNase I treatment (Invitrogen). To synthesize cDNA,
1.5 µg of DNA-free RNA was used for first-strand cDNA synthesis
with random hexamer primers and Superscript III reverse transcription (Invitrogen) according to the company’s protocol. The resulting
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cDNAs were used for PCR amplification using the primers sequences
detailed in Table S2. Quantitative PCR reaction was set using the iTaq
universal SYBR green supermix (Bio-Rad) according to the manufacturer’s protocol. PCR product formation was evaluated using the
CFX-Connect Real Time System (Bio-Rad).
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Means were compared by genotype and age using a factorial analysis
of variance model in which variances were allowed to be heterogeneous, since variance homogeneity did not hold. For pulmonary outcomes in which the same animal was exposed to CO2 and room air
conditions, means were compared by genotype and condition using
a repeated-measure analysis of variance model (mixed model). Post
hoc (under the model) p-values were computed using the Fisher least
significant difference criterion. Residual error normal quartile plots
were examined to confirm that the residual errors followed a normal
distribution, allowing the use of a parametric model. Student’s t test
or Mann–Whitney U test were used for experiments using only two
groups. Values were considered significantly different if P ≤ 0.05.
Online supplemental material

Fig. S1 shows the effect of OPN ablation on macrophage polarization in
acute injury experiments (CTX injection experiments). Fig. S2 provides
information about the degree of improvement caused by OPN ablation in
mdx mice by comparing the performance of C57BL/6J and OPN−/−mdx
mice in different muscle strength tests. Table S1 provides the total cell
number in the different macrophage subtypes per muscle mass, from the
experiments shown in Fig. 4 for 8-wk-old mice. Table S2 summarizes
the sequences of the primers used. Online supplemental material is
available at http://www.jcb.org/cgi/content/full/jcb.201510086/DC1.
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